Faeth Therapeutics, Inc. (FTH) Insider Trading

Over the last 3 months, FTH insiders made 9 open-market buys and 0 sales, a net purchase of $461K (SEC Form 4). Multiple insiders bought within days of each other (cluster buying).

Insider Activity

Sentiment
100/100
Buys (3m)
9
Sells (3m)
0
Net (3m)
$461.4K
Insiders buyingCluster buying
Context3-month price -16.8%
DateInsiderTypeSharesPrice
Jun 24, 2026Parikh Anand Kirandirector, officer: President and CEOOption8,213$1.16
Jun 24, 2026STEPHENSON BRIAN Cofficer: Chief Financial OfficerBuy6,836$24.12
Jun 24, 2026STEPHENSON BRIAN Cofficer: Chief Financial OfficerBuy1,969$24.84
Jun 24, 2026STEPHENSON BRIAN Cofficer: Chief Financial OfficerBuy425$25.91
Jun 24, 2026Parikh Anand Kirandirector, officer: President and CEOBuy2,806$19.76
Jun 24, 2026Parikh Anand Kirandirector, officer: President and CEOOption45,252$1.16
Jun 24, 2026STEPHENSON BRIAN Cofficer: Chief Financial OfficerBuy1,797$20.23
Jun 24, 2026STEPHENSON BRIAN Cofficer: Chief Financial OfficerBuy1,118$20.82
Jun 24, 2026STEPHENSON BRIAN Cofficer: Chief Financial OfficerBuy1,583$22.40
Jun 24, 2026STEPHENSON BRIAN Cofficer: Chief Financial OfficerBuy3,329$23.28
Jun 24, 2026STEPHENSON BRIAN Cofficer: Chief Financial OfficerBuy356$23.95
Jun 16, 2026Hahn Stephen M.directorGrant25,000$13.00
Jun 16, 2026Parikh Anand Kirandirector, officer: President and CEOGrant761
Jun 16, 2026Parikh Anand Kirandirector, officer: President and CEOGrant12,320$1.16
Jun 16, 2026Parikh Anand Kirandirector, officer: President and CEOGrant136,884$1.16
Jun 16, 2026Ramasastry SairadirectorGrant25,000$13.00

Source: FTH SEC Form 4 filings, latest Jun 24, 2026. For informational purposes only — not investment advice.